Rituximab Linked to 10-fold Higher IBD Risk in MS Medscape
Rituximab Linked to 10-fold Higher IBD Risk in MS
ME
MedscapeBy MedscapeEXECUTIVE SUMMARY
Rituximab Linked to 10-fold Higher IBD Risk in MS Medscape
Key Takeaways
- Rituximab Linked to 10-fold Higher IBD Risk in MS.
- Rituximab Linked to 10-fold Higher IBD Risk in MS Medscape Rituximab Linked to 10-fold Higher IBD Risk in MS Medscape
Read Complete Original Article
Published originally on Medscape



